Echoes of infection: viral persistence, immune activation, and histopathological changes in long COVID: a systematic review

Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 (PASC), affects an estimated 10–20% of individuals following SARS-CoV-2 infection. Despite its substantial global burden, the pathophysiological mechanisms remain incompletely understood. This systematic review aimed to synthesize available evidence on viral persistence, immune activation, and histopathological changes across multiple organ systems, drawing from studies of individuals with Long COVID as well as broader post-acute cohorts, autopsy investigations, and case-based reports relevant to Long COVID pathophysiology. Following PRISMA guidelines and holding a PROSPERO registration (CRD420261403869), a systematic literature search was conducted across PubMed, Scopus, EMBASE, and Cochrane CENTRAL. Eligible reports were stratified as (A) symptom-defined Long COVID assessed at or after 12 weeks, (B) post-acute or mixed populations without a consistently confirmed Long COVID definition or timing, (C) autopsy studies, and (D) isolated case/fetal reports. Findings were synthesized narratively by specimen, assay target, and unit of analysis. JBI checklists were used for item-level appraisal, not as certainty-of-evidence ratings. Forty-five reports were included: 16 in stratum A, 23 in stratum B, three autopsy studies, and three isolated case/fetal reports. SARS-CoV-2 genomic RNA, viral proteins, and markers compatible with recent viral activity were reported in selected tissue and blood compartments, but detection varied with population selection, timing, specimen, and assay. No included study established replication competence by recovery of infectious virus. Histopathological abnormalities included inflammatory infiltrates, fibrosis, and vascular injury; however, causal attribution to Long COVID was limited by acute disease severity, biopsy indication, comorbidity, and incomplete comparator data. A single participant total was not reported because of overlapping cohorts, repeated sampling, and outcome-specific denominators. The review supports biological heterogeneity after SARS-CoV-2 infection, including residual viral material, immune dysregulation, vascular injury, and maladaptive tissue repair. Organ-specific prevalence, a hierarchy of tissue tropism, replication-competent reservoirs, and superiority of antiviral or immunomodulatory treatment remain undefined. Standardized Long COVID definitions, representative cohorts, validated assays, appropriate comparators, and longitudinal studies linking biological markers to clinical outcomes are required.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Medicine
Published
2026-11-17
DOI
https://doi.org/10.1007/s10238-026-02339-5
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Echoes of infection: viral persistence, immune activation, and histopathological changes in long COVID: a systematic review

Omnia Azmy Nabeh, Abdelrahman Elmahroky, Abdelrahman Emad Helmy, Hisham Abdelrasoul et al.
Clinical and Experimental Medicine
Long-Term Effects of COVID-19
article

Echoes of infection: viral persistence, immune activation, and histopathological changes in long COVID: a systematic review

Omnia Azmy Nabeh, Abdelrahman Elmahroky, Abdelrahman Emad Helmy, Hisham Abdelrasoul, Menna Badawi, Omar Walid Tanbedawy, Haneen Suliman, Yahya Aly, Aser Farghaly
article en

Abstract

Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 (PASC), affects an estimated 10–20% of individuals following SARS-CoV-2 infection. Despite its substantial global burden, the pathophysiological mechanisms remain incompletely understood. This systematic review aimed to synthesize available evidence on viral persistence, immune activation, and histopathological changes across multiple organ systems, drawing from studies of individuals with Long COVID as well as broader post-acute cohorts, autopsy investigations, and case-based reports relevant to Long COVID pathophysiology. Following PRISMA guidelines and holding a PROSPERO registration (CRD420261403869), a systematic literature search was conducted across PubMed, Scopus, EMBASE, and Cochrane CENTRAL. Eligible reports were stratified as (A) symptom-defined Long COVID assessed at or after 12 weeks, (B) post-acute or mixed populations without a consistently confirmed Long COVID definition or timing, (C) autopsy studies, and (D) isolated case/fetal reports. Findings were synthesized narratively by specimen, assay target, and unit of analysis. JBI checklists were used for item-level appraisal, not as certainty-of-evidence ratings. Forty-five reports were included: 16 in stratum A, 23 in stratum B, three autopsy studies, and three isolated case/fetal reports. SARS-CoV-2 genomic RNA, viral proteins, and markers compatible with recent viral activity were reported in selected tissue and blood compartments, but detection varied with population selection, timing, specimen, and assay. No included study established replication competence by recovery of infectious virus. Histopathological abnormalities included inflammatory infiltrates, fibrosis, and vascular injury; however, causal attribution to Long COVID was limited by acute disease severity, biopsy indication, comorbidity, and incomplete comparator data. A single participant total was not reported because of overlapping cohorts, repeated sampling, and outcome-specific denominators. The review supports biological heterogeneity after SARS-CoV-2 infection, including residual viral material, immune dysregulation, vascular injury, and maladaptive tissue repair. Organ-specific prevalence, a hierarchy of tissue tropism, replication-competent reservoirs, and superiority of antiviral or immunomodulatory treatment remain undefined. Standardized Long COVID definitions, representative cohorts, validated assays, appropriate comparators, and longitudinal studies linking biological markers to clinical outcomes are required.

Clinical and Experimental Medicine
University of Nottingham (GB), Cairo University (EG)
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon